Profil
Laetitia Szaller is currently working as the General Counsel & Head-Compliance at Egetis Therapeutics AB.
Previously, she worked as the VP-Business Development & General Counsel at AM-Pharma BV from 2020 to 2023.
Postes actifs de Laetitia Szaller
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Compliance Officer | 22/12/2023 |
Anciens postes connus de Laetitia Szaller
| Sociétés | Poste | Fin |
|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Conseiller Juridique Général | 01/08/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
